user-generated· product
Ebola vaccine development accelerates by 2027
The ongoing Bundibugyo virus outbreak in the Democratic Republic of Congo will spur increased investment in Ebola vaccine research. With no proven vaccine currently available, global health organizations and pharmaceutical companies will prioritize development, leading to significant progress by 2027.
product · Prediction Market
- Implied probability (Yes)
- 75%
- Closes
- 2027-07-04
More product markets
- Vercel’s Eve framework adoption exceeds 50% among enterprise AI deployments by Dec 2026 — 70% Yes
- OpenAI will delay its 2026 hardware launch due to Apple lawsuit — 55% Yes
- Netflix to introduce micro-episode format by December 2026 — 68% Yes
- Govee Glide Hexa Light Panels will see a 30% increase in sales by Q4 2026 — 70% Yes
- Coinbase launches new staking product by August 2026 — 55% Yes
- Competitor AI models adopt 'J-Space'-like reasoning by 2027-03-31 — 60% Yes
- Tesla partners with Sadi Thermal Machines for next-gen heat pump tech — 60% Yes
- Claude's J-Space adoption accelerates in enterprise AI tools — 70% Yes
Loading…